Tang Capital Management’s C4 Therapeutics CCCC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-900,000
Closed -$2M 97
2025
Q3
$2M Hold
900,000
0.08% 128
2025
Q2
$1.29M Hold
900,000
0.07% 143
2025
Q1
$1.44M Hold
900,000
0.08% 139
2024
Q4
$3.24M Buy
900,000
+200,000
+29% +$994K 0.21% 90
2024
Q3
$3.99M Buy
700,000
+500,000
+250% +$3.01M 0.29% 83
2024
Q2
$924K Buy
+200,000
New +$1.19M 0.09% 96

Other funds holding CCCC

Tang Capital Management's CCCC Position: Q4 2025 in Review

Tang Capital Management sold out of C4 Therapeutics (CCCC) in Q4 2025, closing a stake of 900,000 shares — an estimated $2M sold.

Tang Capital Management first reported a position in CCCC in Q2 2024 and held it in 6 quarters. The position peaked at $3.99M in Q3 2024. 101 funds tracked by Wall St. Rank hold CCCC as of Q4 2025.

  • Tang Capital Management reported no remaining C4 Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Tang Capital Management sold 900,000 C4 Therapeutics shares in Q4 2025, an estimated $2M.
  • Tang Capital Management first reported a position in C4 Therapeutics in Q2 2024 and held it in 6 quarters.
  • Tang Capital Management's C4 Therapeutics position peaked at $3.99M in Q3 2024.
  • 101 funds tracked by Wall St. Rank held C4 Therapeutics as of Q4 2025.

Based on Tang Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.